NCT03878888View on ClinicalTrials.gov

Exparel Use in Bilateral TAP Blocks for Postoperative Pain Control

PHASE4CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

January 15, 2019

Primary Completion Date

July 1, 2019

Study Completion Date

July 1, 2019

Conditions
Postoperative PainSurgeryAnesthesia, Local
Interventions
DRUG

Exparel 266 MG Per 20 ML Injection

patients receive Exparel in bilateral TAP blocks for open abdomen surgery

Trial Locations (1)

18015

St. Luke's University Hospital Health Network, Bethlehem

All Listed Sponsors
lead

St. Luke's Hospital, Pennsylvania

OTHER

NCT03878888 - Exparel Use in Bilateral TAP Blocks for Postoperative Pain Control | Biotech Hunter | Biotech Hunter